CDSCO identifies one spurious and 220 substandard drugs in August exercise
The failed samples during routine regulatory surveillance included 29 samples tested by the central drugs laboratories and 191 identified by the state drugs testing laboratories.
The Central Drugs Standard Control Organisation (CDSCO) identified one spurious and 220 substandard drugs during an August drug surveillance exercise, according to a report issued on Tuesday. The failed samples included 29 tested by central drug laboratories and 191 by state drug testing laboratories. Substandard drugs are those that fail to meet quality standards in areas such as labeling, dissolution, weight uniformity, and sterility.
CDSCO clarified that identifying a drug as NSQ is based on failure in one or more quality parameters, and the finding is specific to a batch tested by a government laboratory. CDSCO and state drug regulators work together to identify and remove NSQ and spurious medicines from the market. The CDSCO's Drugs Controller General of India, Rajeev Singh Raghuvanshi, warned against the indiscriminate use of antibiotics and NSAIDs, as it could lead to chronic kidney disease.
Written by urgent.news from Hindustan Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
